Clinical Trial Update: Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the efficacy, safety, and PK/PD of fimasartan (BR-A-657•K) in adults with essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• Fimasartan (fimasartan)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED